155 related articles for article (PubMed ID: 20672144)
1. Evaluating the suitability of using rat models for preclinical efficacy and side effects with inhaled corticosteroids nanosuspension formulations.
Chiang PC; Hu Y; Blom JD; Thompson DC
Nanoscale Res Lett; 2010 Apr; 5(6):1010-9. PubMed ID: 20672144
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic evaluation of the suitability of using fluticasone and an acute rat lung inflammation model to differentiate lung versus systemic efficacy.
Chiang PC; Hu Y; Thurston A; Sommers CD; Guzova JA; Kahn LE; Lai Y; Blom JD
J Pharm Sci; 2009 Nov; 98(11):4354-64. PubMed ID: 19230021
[TBL] [Abstract][Full Text] [Related]
3. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
Kramer S; Rottier BL; Scholten RJ; Boluyt N
Cochrane Database Syst Rev; 2013 Feb; (2):CD010352. PubMed ID: 23450613
[TBL] [Abstract][Full Text] [Related]
4. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma.
Belvisi MG; Bundschuh DS; Stoeck M; Wicks S; Underwood S; Battram CH; Haddad el-B; Webber SE; Foster ML
J Pharmacol Exp Ther; 2005 Aug; 314(2):568-74. PubMed ID: 15878996
[TBL] [Abstract][Full Text] [Related]
5. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
Dyer MJ; Halpin DM; Stein K
BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
[TBL] [Abstract][Full Text] [Related]
6. Difference between patient-reported side effects of ciclesonide versus fluticasone propionate.
van der Molen T; Foster JM; Caeser M; Müller T; Postma DS
Respir Med; 2010 Dec; 104(12):1825-33. PubMed ID: 20584595
[TBL] [Abstract][Full Text] [Related]
7. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
Lipworth BJ; Kaliner MA; LaForce CF; Baker JW; Kaiser HB; Amin D; Kundu S; Williams JE; Engelstaetter R; Banerji DD
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
[TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations.
Gulliver T; Morton R; Eid N
Paediatr Drugs; 2007; 9(3):185-94. PubMed ID: 17523699
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
Kaliner MA
Clin Ther; 2006 Mar; 28(3):319-31. PubMed ID: 16750447
[TBL] [Abstract][Full Text] [Related]
11. Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features.
Leung SY; Eynott P; Nath P; Chung KF
J Allergy Clin Immunol; 2005 May; 115(5):989-96. PubMed ID: 15867856
[TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy.
Rizzo MC; Solé D
J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S198-205. PubMed ID: 17136296
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
[TBL] [Abstract][Full Text] [Related]
14. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
Buhl R; Vinkler I; Magyar P; Györi Z; Rybacki C; Middle MV; Escher A; Engelstätter R
Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388
[TBL] [Abstract][Full Text] [Related]
15. Ciclesonide: long-term treatment of persistent asthma--no clear progress.
Prescrire Int; 2013 Sep; 22(141):207. PubMed ID: 24171213
[TBL] [Abstract][Full Text] [Related]
16. Ciclesonide: A Pro-Soft Drug Approach for Mitigation of Side Effects of Inhaled Corticosteroids.
Mukker JK; Singh RSP; Derendorf H
J Pharm Sci; 2016 Sep; 105(9):2509-2514. PubMed ID: 27339407
[TBL] [Abstract][Full Text] [Related]
17. Systemic effects of inhaled corticosteroids: an overview.
Pandya D; Puttanna A; Balagopal V
Open Respir Med J; 2014; 8():59-65. PubMed ID: 25674175
[TBL] [Abstract][Full Text] [Related]
18. The properties of inhaled corticosteroids: similarities and differences.
Barnes NC
Prim Care Respir J; 2007 Jun; 16(3):149-54. PubMed ID: 17530144
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma.
Yeo SH; Aggarwal B; Shantakumar S; Mulgirigama A; Daley-Yates P
Expert Rev Respir Med; 2017 Oct; 11(10):763-778. PubMed ID: 28752776
[TBL] [Abstract][Full Text] [Related]
20. Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.
Postma DS; Dekhuijzen R; van der Molen T; Martin RJ; van Aalderen W; Roche N; Guilbert TW; Israel E; van Eickels D; Khalid JM; Herings RM; Overbeek JA; Miglio C; Thomas V; Hutton C; Hillyer EV; Price DB
Allergy Asthma Immunol Res; 2017 Mar; 9(2):116-125. PubMed ID: 28102056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
